Med. praxi. 2010;7(11):408-413

Intestinal microflora, gastrointestinal ecosystem and probiotics

prof.MUDr.Přemysl Frič, DrSc.
Interní klinika 1. lékařské fakulty UK a Ústřední vojenské nemocnice, Praha

Intestinal microflora is a postnatal acquired organ. Its metabolic activities are comparable with liver metabolism. Intestinal microflora, the

mucosal immune system, and the intestinal mucosal barrier constitute a highly integrated complex, the gastrointestinal ecosystem. The

full morphological and functional maturity of individual components requires frequent interactions marked with a brittle equilibrium.

Their disturbances participate in the pathogenesis of many diseases. The probiotics stabilize the functions of individual components

of the gastrointestinal ecosystem and contribute to the constitution and preservation of the physiological equilibrium. Probiotics have the

prerequisites to become a new method of biological therapy.

Keywords: intestinal microflora, gastrointestinal ecosystem, probiotics, prebiotics, synbiotics

Published: January 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Frič P. Intestinal microflora, gastrointestinal ecosystem and probiotics. Med. praxi. 2010;7(11):408-413.
Download citation

References

  1. Ammor MS, Flórez AB, van Hoek AH, et al. Molecular characterization of intrinsic and acquired resistance in lactic acid bacteria and bifidobacteria. J Mol Microbiol Biotechnol 2008; 14: 6-15. Go to original source... Go to PubMed...
  2. Aso Y, Akaza II, Kotake T, et al. Preventive effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104-109. Go to original source... Go to PubMed...
  3. Bauer TM, Schwacha H, Steinbruckner B, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97: 2364-2370. Go to original source... Go to PubMed...
  4. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430-435. Go to original source... Go to PubMed...
  5. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms and evidence of clinical efficacy. J Clin Gastroenterol 2008, 40: 264-269. Go to original source... Go to PubMed...
  6. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn´s disease. Gastroenterology 2000; 118: A-781. Go to original source...
  7. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-2749. Go to original source... Go to PubMed...
  8. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638. Go to original source... Go to PubMed...
  9. Flórez AB, Ammor MS, Mayo B. Identification of tet (M) in two Lactococcus lactis strains isolated from a Spanish traditional starter-free cheese made of raw milk and conjugative transfer of tetracycline resistance to lactococci and enterococci. Int J Food Microbiol 2008; 31: 189-194. Go to original source... Go to PubMed...
  10. Food and Agriculture Organizaton of the United Nations and World Health Organization: Regulatory and Clinical Aspects of dairy probiotics. Expert Consultation Report (posting date 2001) and Working Group Report (online).
  11. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 2008; 24: 4-10. Go to original source... Go to PubMed...
  12. Frič P. Probiotika a prebiotika - renesance terapeutického principu. I. Teorie a experimentální doklady. Postgrad medicina 2005; 7: 472-477.
  13. Frič P. Význam gastrointestinálního ekosystému. Postgrad Med 2009; 11: 658-661.
  14. Frič P. Probiotika a prebiotika v praxi. Medicina po promoci 2007; 8(6): 57-60.
  15. Frič P. Probiotika a prebiotika - renesance terapeutického principu. II. Klinické aplikace. Postgrad medicina 2005; 7: 588-592.
  16. Frič P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003; 15: 313-315. Go to original source...
  17. Frič P. Probiotika, prebiotika a atopie. Dermatolog praxi 2007; 2: 87-89.
  18. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005; 54: 242-249. Go to original source... Go to PubMed...
  19. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998; 80: S209-S212. Go to original source... Go to PubMed...
  20. Gionchetti O, Rizzello F, Helwig U, et al: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209. Go to original source... Go to PubMed...
  21. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309. Go to original source... Go to PubMed...
  22. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95: S2-54. Go to original source... Go to PubMed...
  23. Guandalini S, Pensabene L, Zikri MA. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial. J Pediatr. Gastroenterol Nutr 2000; 30: 54-60. Go to original source... Go to PubMed...
  24. Hoesl CE, Altwein JE. The probiotic approach: an alternative treatment option in urology. Eur Urol 2005; 47: 288-296. Go to original source... Go to PubMed...
  25. Kruis W, Frič P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623. Go to original source... Go to PubMed...
  26. Lestin F, Pertschy A, Rimek D. Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple co-morbidities. Dtsch Med Wschr 2003; 128: 2531-2533. Go to original source... Go to PubMed...
  27. Ley RE, Turnbaugh PJ, Klein S, Gordon JL. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023. Go to original source... Go to PubMed...
  28. Lherm Z, Monet C, Nougiere B, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002; 28: 797-801. Go to original source... Go to PubMed...
  29. Linsalata M, Russo F, Berloco P, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004; 9: 165-172. Go to original source... Go to PubMed...
  30. Liu O, Duan Z, Ha D, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encefalopathy in patiens with cirrhosis. Hepatology 2004; 39: 1441-1449. Go to original source... Go to PubMed...
  31. Mc Cracken WJ, Lorenz RG. The gastrointestinal ecosystem: a precarious aliance among epithelium, imunity and microbiota. Cell Microbiol 2001; 3: 1-11. Go to original source... Go to PubMed...
  32. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 2007; 65: 282-285. Go to original source...
  33. Nordgaard I, Mortensen PB. Digestive processes in the human colon. Nutrition 1995; 11: 37-45.
  34. Nougayrede JP, Homburg S, Taleb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryocytic cells. Science 2006; 313: 848-851. Go to original source... Go to PubMed...
  35. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000; 95: S11-S13. Go to original source... Go to PubMed...
  36. Reid G, Sanders ME, Gaskins HR, et al. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003; 37: 105-118. Go to original source... Go to PubMed...
  37. Roberfroid MB. Prebiotics and symbiotics: concepts and nutritional properties. Br J Nutr 1998; 80: S197-S202. Go to original source... Go to PubMed...
  38. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126: 1620-1633. Go to original source... Go to PubMed...
  39. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005; 21: 44-50. Go to PubMed...
  40. Spiller R. Role of infection in irritable bowel disease. J. Gastroenterol 2007; 42: 41-47. Go to original source... Go to PubMed...
  41. Tursi A, Brandimarte G, Giorgetti GM, et al. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004; 10: 126-131.
  42. van Hoek AH, Mayrhofer S, Domig KJ, et al. Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii. Antimicrob Agents Chemother 2008; 52: 248-252. Go to original source... Go to PubMed...
  43. Zhao H, Wang H, Xu S, et al. Intestinal microflora in patiens with liver cirrhosis. Chin J Dig Dis 2004; 5: 64-67. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.